Lisa D. Earnhardt
Executive Vice President, Abbott Laboratories.
Companies
- Abbott LaboratoriesExecutive Vice President Jun 12, 2019 to now1
- Intersect ENTBoard member Jul 23, 2014 to Jul 26, 20192
- Intersect ENTChief executive officer Jan 23, 2015 to May 17, 20193
- Intersect ENTPresident Jan 23, 2015 to May 17, 20193
- NEVRO CORPBoard member Jul 1, 2015 to May 23, 20184
- Intersect ENTOfficer Jul 23, 2014 to Apr 17, 20152
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT90,407 shares5$9.5M at $104.71Feb 27, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 27, 2026Shares withheld for tax 8,577 shares at $116.26 of Abbott Laboratories5
- Feb 24, 2026Granted 27,056 shares of Abbott Laboratories6
- Mar 7, 2025Sold 200 shares at $136.65 of Abbott Laboratories7
- Mar 7, 2025Exercised options 200 shares at $80.98 of Abbott Laboratories7
- Mar 6, 2025Sold 91,167 shares at $133.82 of Abbott Laboratories7
- Mar 6, 2025Exercised options 91,167 shares at $80.98 of Abbott Laboratories7
- Feb 28, 2025Shares withheld for tax 8,322 shares at $135.87 of Abbott Laboratories8
- Feb 25, 2025Granted 18,788 shares of Abbott Laboratories9
- May 7, 2024Sold 22,852 shares at $106.25 of Abbott Laboratories10
- Mar 1, 2024Sold 694 shares at $118.50 of Abbott Laboratories11
- Feb 29, 2024Shares withheld for tax 7,669 shares at $120.05 of Abbott Laboratories11
- Feb 21, 2024Granted 17,240 shares of Abbott Laboratories12
- Mar 1, 2023Sold 943 shares at $100.70 of Abbott Laboratories13
- Feb 28, 2023Shares withheld for tax 7,631 shares at $99.77 of Abbott Laboratories13
- Feb 17, 2023Granted 15,855 shares of Abbott Laboratories14
- Jun 10, 2022Shares withheld for tax 19,592 shares at $112.71 of Abbott Laboratories15
- Jun 10, 2022Shares withheld for tax 2,882 shares at $112.71 of Abbott Laboratories15
- Mar 1, 2022Sold 943 shares at $118.15 of Abbott Laboratories16
- Feb 28, 2022Shares withheld for tax 5,168 shares at $122.41 of Abbott Laboratories16
- Feb 18, 2022Granted 17,247 shares of Abbott Laboratories17
- Jun 10, 2021Shares withheld for tax 2,881 shares at $109.05 of Abbott Laboratories18
- Mar 1, 2021Sold 943 shares at $120.61 of Abbott Laboratories19
- Feb 26, 2021Shares withheld for tax 2,621 shares at $121.58 of Abbott Laboratories19
- Feb 19, 2021Granted 13,865 shares of Abbott Laboratories20
- Jun 10, 2020Sold 872 shares at $90.84 of Abbott Laboratories21
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Mar 7, 2025 | ABT | Sale | $27.3K | −23.5% | +57.5% | +35.6% |
| Mar 6, 2025 | ABT | Sale | $12.2M | −22.3% | +57.1% | +36.3% |
| May 7, 2024 | ABT | Sale | $2.4M | −1.2% | +50.4% | −17.7% |
| Mar 1, 2024 | ABT | Sale | $82.2K | −11.6% | +62.1% | −4.4% |
| Mar 1, 2023 | ABT | Sale | $95.0K | +4.0% | +91.5% | +11.0% |
| Mar 1, 2022 | ABT | Sale | $111.4K | −11.2% | +90.7% | +6.5% |
| Mar 1, 2021 | ABT | Sale | $113.7K | −14.2% | +112.3% | +13.7% |
| Jun 10, 2020 | ABT | Sale | $79.2K | +13.8% | +128.1% | +13.3% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARIntersect ENT, Board member
- 3
- 4SEC EDGARNEVRO CORP, Board member
- 5
- 6SEC EDGARForm 4 filed Feb 26, 2026
- 7SEC EDGARForm 4 filed Mar 7, 2025
- 8SEC EDGARForm 4 filed Mar 4, 2025
- 9SEC EDGARForm 4 filed Feb 27, 2025
- 10SEC EDGARForm 4 filed May 8, 2024
- 11SEC EDGARForm 4 filed Mar 4, 2024
- 12SEC EDGARForm 4 filed Feb 23, 2024
- 13SEC EDGARForm 4 filed Mar 2, 2023
- 14SEC EDGARForm 4 filed Feb 22, 2023
- 15SEC EDGARForm 4 filed Jun 14, 2022
- 16SEC EDGARForm 4 filed Mar 2, 2022
- 17SEC EDGARForm 4 filed Feb 23, 2022
- 18SEC EDGARForm 4 filed Jun 11, 2021
- 19SEC EDGARForm 4 filed Mar 2, 2021
- 20SEC EDGARForm 4 filed Feb 23, 2021
- 21SEC EDGARForm 4 filed Jun 12, 2020